Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 3:14 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2857–2880 of 3,580 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: patch Clear all

Conditions: Cigarette Smoking
Interventions: Smoking counseling, Text messaging, Nicotine patch; Behavioral · Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 24 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Atopic Dermatitis
Interventions: BRT-FC-83C; Device
Lead sponsor: Biomed Research & Technologies, Inc.; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 1
States / cities: Colorado Springs, Colorado

Conditions: Smoking Cessation
Interventions: Empowering Cessation for the ACS South; Other
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 100 Years
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Rett Syndrome
Interventions: Emerald; Device
Lead sponsor: Rett Syndrome Research Trust; Other
Eligibility: Female only
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Tendonitis, Bursitis
Interventions: Ketoprofen Topical Patch 20%, Placebo; Drug · Other
Lead sponsor: Alkemira SA; Industry
Eligibility: 18 Years and older
Enrollment: 381 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Turner Syndrome, Hypogonadism, Premature Ovarian Failure
Interventions: 17 B estradiol orally, 17 B estradiol; Drug
Lead sponsor: Nemours Children's Clinic; Other
Eligibility: 13 Years to 20 Years · Female only
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2012
U.S. locations: 2
States / cities: Jacksonville, Florida • Philadelphia, Pennsylvania

Conditions: Endometriosis
Interventions: Robotic surgery, Laparoscopic Surgery; Procedure
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older · Female only
Enrollment: 73 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 3
States / cities: Scottsdale, Arizona • Boston, Massachusetts • Cleveland, Ohio

Conditions: Breast Cancer
Interventions: Molecular Breast Imaging; Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 40 Years and older · Female only
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Amblyopia
Interventions: Eye Patch; Device
Lead sponsor: Jaeb Center for Health Research; Other
Eligibility: 3 Years to 7 Years
Enrollment: 169 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 2
States / cities: Fullerton, California • Durham, North Carolina

Conditions: Contraception
Interventions: Contraceptive Screening by Pharmacist, Contraceptive Prescribing by Pharmacist; Behavioral
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 250 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2006
U.S. locations: 5
States / cities: Kent, Washington • Kirkland, Washington • Puyallup-South Hill, Washington + 2 more

Conditions: Coronary Artery Stenosis
Interventions: BioNIR, Resolute; Device
Lead sponsor: Medinol Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 1,919 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Head And Neck Cancer, Oropharynx Cancer
Interventions: Visual Examination, OraTest; Other · Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 45 Years and older
Enrollment: 1 participant
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Primary Ovarian Insufficiency
Interventions: Hormone Replacement Therapy, Combined Oral Contraceptives; Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 14 Years to 45 Years · Female only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: ADHD
Interventions: Nicotine, Placebo; Drug · Other
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years to 45 Years
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Irvine, California

Conditions: Atrial Fibrillation
Interventions: ELECTROCARDIOGRAM (ECG) PATCH WEAR; Device
Lead sponsor: Apple Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 573 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 4
States / cities: Coral Gables, Florida • Avon, Indiana • Wichita, Kansas + 1 more

Conditions: Primary Axillary Hyperhidrosis
Interventions: Roll-In Cohort: Single Application of N-SWEAT Patch, Randomized Cohort: Single Application of N-SWEAT Patch, Randomized Cohort: Single Application of Sham Patch; Device
Lead sponsor: Candesant Biomedical, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 9
States / cities: Encinitas, California • Fremont, California • Rockville, Maryland + 6 more

Conditions: Head and Neck Cancer, Oropharyngeal Cancer, Hypopharyngeal Cancer, Upper Aerodigestive Tract Neoplasms
Interventions: da Vinci® Robotic System; Procedure
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 20 Years and older
Enrollment: 170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2015
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Smoking Cessation
Interventions: Standard Care, Precision pharmacotherapy; Behavioral
Lead sponsor: Christiana Care Health Services; Other
Eligibility: 18 Years and older
Enrollment: 37 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Newark, Delaware

Conditions: Coronary Artery Disease, Microvascular Coronary Artery Disease
Interventions: Resting distal coronary to aortic pressure ratio, Fractional flow reserve, Coronary Flow Reserve, Microvascular resistance; Diagnostic Test
Lead sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Other
Eligibility: 18 Years and older
Enrollment: 2,322 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Colorectal Neoplasms, Colonic Polyps, Colorectal Cancer
Interventions: Olympus Colonoscope CFHQ190AL; Device
Lead sponsor: VA Palo Alto Health Care System; Federal
Eligibility: 18 Years and older
Enrollment: 281 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2016
U.S. locations: 3
States / cities: Palo Alto, California • San Francisco, California • Kansas City, Missouri

Conditions: Tobacco Cessation, Peripheral Artery Disease
Interventions: Tobacco Treatment Research Program Standard Care; Behavioral
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 100 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Rib Fractures
Interventions: Cryoneurolysis of Intercostal Nerves, Standard of Care; Device · Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 64 Years
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Healthy, Inflammation, Mouth Disease, Pain
Interventions: Not listed
Lead sponsor: National Institute of Dental and Craniofacial Research (NIDCR); NIH
Eligibility: Not listed
Enrollment: 275 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2002
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Malignant Glioma, Ependymoma, Diffuse Intrinsic Pontine Glioma
Interventions: Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields), Concurrent Optune and RT followed by Optune System alone; Device · Combination Product
Lead sponsor: Children's Oncology Group; Network
Eligibility: 3 Years to 21 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2032
U.S. locations: 11
States / cities: Phoenix, Arizona • Los Angeles, California • Palo Alto, California + 8 more

Search by objective public record fields.

Text Messaging for Smoking Cessation in College Health Clinics

A Study of BRT-FC-83C for the Treatment of Atopic Dermatitis

Empowering Cessation ACS South Region

ASSESSING EMERALD AND MC10 BIOSTAMP nPOINT BIOSENSORS FOR RETT SYNDROME

Efficacy and Safety of Ketoprofen Topical Patch 20% in the Treatment of Pain Associated With Shoulder, Elbow or Knee Tendonitis or Bursitis

Estrogen Dosing in Turner Syndrome: Pharmacology and Metabolism

Laparoscopy vs. Robotic Surgery for Endometriosis (LAROSE): a Prospective Randomized Controlled Trial

Pilot Study: Combined Molecular Breast Imaging/Ultrasound System for Diagnostic Evaluation of MBI-detected Lesions

Increasing Patching for Amblyopia in Children 3 to < 8 Years Old

The Direct Access Study: Access to Hormonal Birth Control Through Community Pharmacies

Study of BioNIR Drug Eluting Stent System in Coronary Stenosis

OraTest in Combination With Visual Examination and Visual Examination Alone

Hormone Replacement for Premature Ovarian Insufficiency

Nicotine and Behavior in Adult ADHD

Atrial Fibrillation Algorithms Clinical Validation Study

Evaluation of N-SWEAT Patch for Treatment of Primary Axillary Hyperhidrosis or Excessive Axillary Sweating

Robotic Assisted Surgery in Upper Aerodigestive Tract Surgery

Precision Pharmacotherapy Smoking Cessation Program

Inclusive Invasive Physiological Assessment in Angina Syndromes Registry

Study of Flat Polyp Detection Using New Narrow Band Imaging (NBI) Compared to White Light Colonoscopy - The FIND FLAT Colonoscopy Study

Onsite Tobacco Cessation Treatment for Patients With PAD

Treatment of Adult Traumatic Rib Fractures With Percutaneous Cryoneurolysis

Using a Narcotic to Enhance the Numbing Effect of the Local Anesthetic Lidocaine on Inflamed Molar Teeth

Optune for Children With High-Grade Glioma or Ependymoma, and Optune With Radiation Therapy for Children With DIPG